55 related articles for article (PubMed ID: 322578)
41. Purification of specific heterologous F(ab)2 fragments with DEAE-Zeta-Prep cartridges for ion-exchange chromatography.
Benanchi PL; Gazzei G; Giannozzi A
J Chromatogr; 1988 Oct; 450(1):133-8. PubMed ID: 3220921
[TBL] [Abstract][Full Text] [Related]
42. "PEPSITENSIN"--A HYPERTENSINLIKE SUBSTANCE PRODUCED BY PEPTIC DIGESTION OF PROTEINS.
Croxatto H; Croxatto R
Science; 1942 Jan; 95(2456):101-2. PubMed ID: 17757333
[No Abstract] [Full Text] [Related]
43. Production and characterization of pepsin fragments of human IgA1 to determine domain-specificity of monoclonal anti-IgA antibodies.
Biewenga J; Faber A; Pronk JC; Haaijman JJ
Immunology; 1986 Sep; 59(1):153-8. PubMed ID: 3093370
[TBL] [Abstract][Full Text] [Related]
44. Enzymatic fragmentation of human IgA F(abc)'2: a new peptic fragment.
Rivat C; Bourguignon J; Fontaine M; Ropartz C
Immunochemistry; 1977 Jan; 14(1):69-73. PubMed ID: 321335
[No Abstract] [Full Text] [Related]
45. Disulfide bonding of secretory component to a single monomer subunit in human secretory IgA.
Underdown BJ; De Rose J; Plaut A
J Immunol; 1977 May; 118(5):1816-21. PubMed ID: 404358
[TBL] [Abstract][Full Text] [Related]
46. Dermatitis herpetiformis: 'pH optimum' for the release of potentially antigen-binding IgA fragments from papillary dermis of uninvolved skin by peptic digestion.
Egelrud T; Bäck O
Arch Dermatol Res; 1985; 278(1):44-8. PubMed ID: 3938200
[TBL] [Abstract][Full Text] [Related]
47. Secretory component delays the conversion of secretory IgA into antigen-binding competent F(ab')2: a possible implication for mucosal defense.
Crottet P; Corthésy B
J Immunol; 1998 Nov; 161(10):5445-53. PubMed ID: 9820520
[TBL] [Abstract][Full Text] [Related]
48. [Two new peptic fragments of human IgA: F(abc)'2Alpha and [F(abc)'2]2alpha (author's transl)].
Rivat C; Bourguignon J; Fontaine M; Ropartz C
Ann Immunol (Paris); 1977; 128(1-2):183-4. PubMed ID: 322578
[TBL] [Abstract][Full Text] [Related]
49.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
50.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
51.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
52.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
53.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
54.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
55.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
